Graham K. Cooper, CFO and Treasurer at Orexigen Therapeutics, Inc. (OREX), sold 17,500 shares at $8.40 ($147K) on 2009-12-21, disclosed to the SEC on 2009-12-23.
Open-market sale of $147k OREX by CFO and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.36 | 5,400 | $45K | 30.7% |
| 2 | $8.37 | 1,300 | $11K | 7.4% |
| 3 | $8.38 | 400 | $3K | 2.3% |
| 4 | $8.39 | 3,100 | $26K | 17.7% |
| 5 | $8.40 | 200 | $2K | 1.1% |
| 6 | $8.40 | 800 |
| $7K |
| 4.6% |
| 7 | $8.41 | 1,101 | $9K | 6.3% |
| 8 | $8.42 | 699 | $6K | 4.0% |
| 9 | $8.43 | 2,200 | $19K | 12.6% |
| 10 | $8.44 | 1,500 | $13K | 8.6% |
| 11 | $8.45 | 600 | $5K | 3.5% |
| 12 | $8.46 | 200 | $2K | 1.2% |
| Total | $8.39 avg | 17,500 | $147K | 100% |
| Filing → |
| RCPT | SELL | 2014-09-17 | $3.1M | — | Filing → |
| OREX | SELL | 2009-12-23 | $678K | — | Filing → |
| OREX | SELL | 2008-08-25 | $99K | — | Filing → |